Biblio

Found 39 results
Author [ Keyword(Desc)] Title Type Year
Filters: Author is Robert A Burger  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
80 and over Antineoplastic Combined Chemotherapy Protocols/*administration & dosage/adverse effects Carcinoma/drug therapy/pathology/surgery Cisplatin/*administration & dosage/adverse effects Combined Modality Therapy Drug Administration Schedule Female
D. Armstrong, Bundy, B. N., Wenzel, L. B., Huang, H., Baergen, R., Lele, S., Copeland, L., Walker, J. L., Burger, R. A., and Group, G. Oncology, Intraperitoneal cisplatin and paclitaxel in ovarian cancer, N Engl J Med, vol. 354, pp. 34-43, 2006.
80 and over Antineoplastic Combined Chemotherapy Protocols/*therapeutic use Area Under Curve Carboplatin/*administration & dosage Cisplatin/*administration & dosage Combined Modality Therapy Female Humans Middle Aged Neoplasm Staging Ovarian Neoplasms/*d
R. F. Ozols, Bundy, B. N., Greer, B. E., Fowler, J. M., Clarke-Pearson, D. L., Burger, R. A., Mannel, R., DeGeest, K., Hartenbach, E. M., Baergen, R., and Group, G. Oncology, Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study, J Clin Oncol, vol. 21, pp. 3194-200, 2003.
80 and over Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use Cisplatin/administration & dosage Disease-Free Survival Endometrial Neoplasms/*drug therapy/mortality Female Granulocyte Colony-Stimulating Factor/administration
G. F. Fleming, Brunetto, V. L., Cella, D., Look, K. Y., Reid, G. C., Munkarah, A. R., Kline, R., Burger, R. A., Goodman, A., and Burks, R. T., Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study, J Clin Oncol, vol. 22, pp. 2159-66, 2004.
Abdominal Pain/chemically induced Adenocarcinoma/*drug therapy/pathology/surgery Adult Aged Aged
D. Armstrong, Bundy, B. N., Wenzel, L. B., Huang, H., Baergen, R., Lele, S., Copeland, L., Walker, J. L., Burger, R. A., and Group, G. Oncology, Intraperitoneal cisplatin and paclitaxel in ovarian cancer, N Engl J Med, vol. 354, pp. 34-43, 2006.
Local/blood/drug therapy Ovarian Neoplasms/*blood/*drug therapy Peritoneal Neoplasms/*blood/*drug therapy Predictive Value of Tests Retrospective Studies
L. M. Randall, Sill, M. W., Burger, R. A., Monk, B. J., Buening, B., and Sorosky, J. I., Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a Gynecologic Oncology Group phase II trial, Gynecol Oncol, vol. 124, pp. 563-8, 2012.

Pages